Management of dyslipidemias in patients with diabetes and chronic kidney disease
ME Molitch - Clinical Journal of the American Society of …, 2006 - journals.lww.com
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
Management of dyslipidemias in patients with diabetes and chronic kidney disease.
ME Molitch - Clinical journal of the American Society of …, 2006 - scholars.northwestern.edu
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
[引用][C] Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
ME Molitch - Clinical Journal of the American Society of Nephrology, 2006 - cir.nii.ac.jp
Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[PDF][PDF] Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
Clin J Am Soc Nephrol, 2006 - Citeseer
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
Management of dyslipidemias in patients with diabetes and chronic kidney disease.
ME Molitch - Clinical Journal of the American Society of Nephrology …, 2006 - europepmc.org
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
Management of dyslipidemias in patients with diabetes and chronic kidney disease
ME Molitch - Clinical journal of the American Society of …, 2006 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
[PDF][PDF] Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease
Clin J Am Soc Nephrol, 2006 - scholar.archive.org
Cardiovascular disease (CVD) is the leading cause of death in patients with stage 5 chronic
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …
kidney disease (CKD), and the mortality rate in stage 5 CKD is even higher in patients with …